Biotech Inscript

About Publications Sign in Subscribe

Former Google AI Expert's Biotech Start-Up Raises $100 Million for AI-Driven Drug Innovation

Former Google AI Expert's Biotech Start-Up Raises $100 Million for AI-Driven Drug Innovation

Inceptive, founded by a former Google AI expert, secures $100M in funding from investors like Nvidia and Andreessen Horowitz to advance AI-driven biotech initiatives

Top Stories

Roche to Acquire Carmot Therapeutics in a $3.1 Billion Deal

Roche to acquire Carmot Therapeutics for $3.1B, gaining access to innovative obesity and diabetes treatments. The deal includes clinical-stage assets with potential for standalone and combination therapies. Expected to close in Q1 2024, pending regulatory approval.

Samsung Biologics and VC Firm Kurma Partners Announce Biologics Manufacturing Partnership for Kurma's Portfolio Companies

Samsung Biologics & Kurma Partners team up for biologics development & manufacturing, empowering startups in Kurma's portfolio with tailored CMC services & global expertise. A strategic partnership driving biopharmaceutical innovation.

Edesa Biotech Secures C$23 Million Canadian Govt. Funding to Accelerate Breakthrough Immune Treatment

Edesa Biotech secures C$23 million in government funding for Phase 3 clinical study of EB05, a pioneering immune therapy, as announced in their press release. The funding reinforces their commitment to advancing healthcare innovation.

Latest

Medtech Advancements: Bionic Hand Breakthrough Allows Precise Finger Control Like Never Before

12 July, 2023: A team of multidisciplinary surgeons and engineers, led by Professor Max Ortiz Catalan, an expert in bionics and neural prosthetics, and Professor of Bionics at Chalmers University of Technology in Sweden, have achieved a groundbreaking milestone by creating a novel bionic hand, granting individuals with arm amputations

Breakthrough In Genetic Research: New Method Traces Genomic Variants To Genetic Disorders

JULY 9, 2023: A review of 13 trials using a genotype-first strategy in patient care was done by National Institutes of Health (NIH) researchers. In contrast to the conventional phenotype-first method, which begins with clinical observations, the genotype-first approach focuses on identifying patients with specific genomic variations and subsequently studying

Scientists Unveil Promising Bacterial Blueprint to Combat Antibiotic Resistance

01 July, 2023: A global team of scientists, including researchers from Trinity College Dublin, has achieved detailed knowledge about the structure of a crucial bacterial enzyme. This breakthrough could assist chemists in developing novel medications to inhibit the enzyme and effectively combat disease-causing bacteria. The significance of their research cannot

NHS Introduces Life-Saving Drug For Premature Babies' Vision

4 July 2023: Premature infants in England can now receive drug treatment as a routine measure on the National Health Service (NHS), aimed at preventing blindness. This marks the first instance where such treatment is made available for premature babies within the NHS in England. Normally, infants who have Retinopathy

Biomedical Engineering Breakthroughs: Transforming Healthcare for Tomorrow

Biomedical engineering has emerged as a dynamic field at the intersection of healthcare and technology, offering a multitude of groundbreaking discoveries and innovations that have the potential to revolutionise healthcare. From novel medical devices and implants to cutting-edge diagnostic tools and regenerative therapies, biomedical engineering is paving the way for

CHMP Grants Authorisation for GSK's Groundbreaking CKD Drug

London, 26 June 2023: Leading global pharmaceutical company GSK plc has made an announcement stating that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has provided a favourable opinion recommending the authorization of daprodustat. The recommendation is specifically for the treatment of symptomatic anaemia linked to

Breakthrough in Diabetes Treatment: Scientists Unveil Affordable and Safer Plant-Based Oral Insulin

June 15, 2023: Scientists have created an insulin derived from plants, specifically lettuce, which is claimed to be a more affordable and secure substitute for regular hormone injections. A recent study led by Henry Daniell from Penn's School of Dental Medicine, published in the journal Biomaterials, highlights the potential of